IL6 and myocardial infarction: In this sub-study of the ASSessing the effect of Anti-IL-6 treatment in Myocardial Infarction (ASSAIL-MI) trial, we aimed to explore differences in m6A methylation sites between healthy individuals and patients with STEMI at time of hospitalization, and how this affected gene expression of the targeted mRNA.